SCHEMBL4710063

SCHEMBL4710063

Cc1ccc(CN(C)C)c(C=Cc2ccccc2Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.40
FGFR3 P22607 1/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 3/20 0.40
CYP1A2 P05177 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CHAT P28329 1/20 0.36
ALDH1A1 P00352 3/20 0.36
RELA Q04206 1/20 0.35
NFE2L2 Q16236 1/20 0.35
NPC1 O15118 4/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710062 1.00 FGFR1 (0.40) FGFR1FGFR3SLC6A2SLC6A4SLC6A3
SCHEMBL4711228 0.83 FGFR1 (0.41) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL4711231 0.83 FGFR1 (0.41) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL7267902 0.79 FGFR1 (0.44) FGFR1FGFR3RAB9ASMN1; SMN2NPC1
SCHEMBL7262186 0.76 CYP1A2 (0.43) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL4714522 0.76 MEN1 (0.47) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL4714523 0.76 MEN1 (0.47) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL7262198 0.76 FGFR1 (0.44) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL4713060 0.71 RAB9A (0.46) FGFR1FGFR3CYP1A2CYP1A1CYP1B1
SCHEMBL4713064 0.71 RAB9A (0.46) FGFR1FGFR3CYP1A2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed